The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

By B. Delahunt, John C. Cheville, G. Martignoni, P. Humphrey, C. Magi-Galluzzi, J. McKenney, L. Egevad, F. Algaba, H. Moch, D. Grignon and 2 more. American Journal of Surgical Pathology, 2013

753 citations recorded by the source corpus.

Subfields: Molecular Biology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/7cf6b28828e8d7d4dd7243f66a3931ad8efb1994

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. B. Escudier
2. C. Porta
3. M. Schmidinger
4. N. Rioux-Leclercq
5. A. Bex
6. V. Grünwald
7. H. Moch
8. A. Horwich

Citations in the corpus

• The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. (2016, methodology): “Fourth, the novel WHO/ISUP grading system has been validated for ccRCC and papillary RCC but not for other tumour types [34].”
• Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. (2019, methodology): “The prognostic factors validated by the International Society of Urological Pathology (ISUP) consensus and the WHO 2016 classification of RCC to be reported in routine practice are [13]:  The tumour histological subtype  The ISUP nucleolar grade (instead of the previous Fuhrman grade) that is only”